Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital, Biotechnology, Pharmaceuticals
Stage Focus
Seed, Early Stage, Growth, Late Stage, Pre-IPO, Buyout
Geographical Focus
United States, China
Industries Focus
- Healthcare Services
- Pharmaceuticals
- Biotechnology
- Medical Technology
- Gene Technology
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2018
Sherpa Healthcare Partners is a Beijing-based private equity firm specializing in healthcare investments across China and the United States. The firm focuses on early to growth-stage investments in the pharmaceutical, biotechnology, medical technology, and healthcare services sectors. Their portfolio includes companies in gene technology and related industries.
The firm's investment strategy encompasses a wide range of stages, from seed and early-stage ventures to growth, late-stage, pre-IPO, and buyout opportunities. This approach allows them to support companies at various points in their development, providing tailored resources and expertise to foster growth and innovation.
Sherpa Healthcare Partners has established a robust portfolio, fostering enduring value and collaborative partnerships within the healthcare industry. Their commitment to building lasting connections enables them to provide comprehensive, all-cycle services that leverage essential resources for their portfolio companies.
Requirements
- Focus on healthcare sectors
- Early to growth-stage companies
- Presence in China or the United States
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Alamar Biosciences
- Appia Bio
- Mattermark
- Archimedes Vascular
- AusperBio
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$39.95
-
$99.00
Claim this Investor
Are you an official representative of Sherpa Healthcare Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim